✦ LIBER ✦

Safety Considerations with Gastrointestinally Active Lipid-Lowering Drugs

✍ Scribed by Terry A. Jacobson; Annemarie Armani; James M. McKenney; John R. Guyton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expert Commentary: Gastrointestinally Ac

✍ Peter P. Toth 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A Comprehensive Description of Muscle Sy

✍ Sylvia Franc; Sylvie Dejager; Eric Bruckert; Marina Chauvenet; Philippe Giral; G 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 88 KB

Lipid-Lowering Efficacy and Safety After

✍ Dr. Sean T. Nguyen; Dr. Susan A. Eaton; Dr. Amy M. Bain; Dr. Anita P. Rahman; Dr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Genetic risk factors associated with lip

✍ Georgirene D. Vladutiu; Zachary Simmons; Paul J. Isackson; Mark Tarnopolsky; Wen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Lipid-lowering drugs are associated with

✍ Eugénie Mutez; Alain Duhamel; Luc Defebvre; Régis Bordet; Alain Destée; Alexandr 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Nonsteroidal Antiinflammatory Drugs Are

✍ C. Mel Wilcox; Lorraine N. Alexander; George A. Cotsonis; W. Scott Clark 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 130 KB